FDA clears Scopio Labs digital cell morphology platform
Scopio Labs received FDA 510(k) clearance for its X100HT hematology digital cell morphology platform with peripheral blood smear review.
Link to full article
In the media
Back to news lobby
July 27, 2025
Scopio Labs Unveils First-of-Its-Kind AI-Powered Solution to Fully Automate Blood Morphology
Scopio’s Complete Blood Morphology (CBM®) ushers in a new era of lab automation, analyzing 10x more cells than the current standard of care in blood cell morphology, addressing global laboratory staffing...
Read more
July 10, 2025
Scopio Labs Receives Fourth FDA Clearance, Elevating Digital Morphology with Enhanced AI-Powered RBC and Platelet Capabilities
TEL AVIV, ISRAEL – July 10, 2025 /PRNewswire/ – Scopio Labs, a trailblazer in Full-Field Digital Cell Morphology, today announced another significant milestone: its fourth U.S. Food and Drug Administration...
Read more
January 14, 2025
Scopio Labs and Siemens Healthineers Extend Alliance to Include Digital Bone Marrow Aspirate Solution
Adding this important digital innovation to the Siemens Healthineers hematology portfolio supports the needs of pathology and hematopathology laboratories and can ultimately lead to better patient outcomes...
Read more
